- Home
- Publications
- Publication Search
- Publication Details
Title
New approaches to the treatment of nephropathy in diabetes
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 20, Issue 8, Pages 1057-1071
Publisher
Informa Healthcare
Online
2011-07-12
DOI
10.1517/13543784.2011.591785
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
- (2011) Pablo E. Pergola et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
- (2010) Pantelis A. Sarafidis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Rosiglitazone Revisited
- (2010) Steven E. Nissen et al. ARCHIVES OF INTERNAL MEDICINE
- Prevention of diabetic nephropathy in Ins2+/−AkitaJmice by the mitochondria-targeted therapy MitoQ
- (2010) Balu K. Chacko et al. BIOCHEMICAL JOURNAL
- Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats
- (2010) Yoshihiro Kuno et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
- (2010) Nina Reiniger et al. DIABETES
- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
- (2010) A. Alkhalaf et al. DIABETES CARE
- The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial
- (2010) M. D. Witham et al. DIABETOLOGIA
- The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology
- (2010) Wendy C. Burns et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure
- (2010) Radko Komers et al. KIDNEY INTERNATIONAL
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- The expanding spectrum of biological actions of vitamin D
- (2010) J. Rojas-Rivera et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
- (2009) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2009) Helen M. Colhoun et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability
- (2009) Xiaohua Guo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates
- (2009) Steven C. Zammit et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The impact of diabetes mellitus on vitamin D metabolism in predialysis patients
- (2009) Hirotaka Tanaka et al. BONE
- Potential for vitamin D receptor agonists in the treatment of cardiovascular disease
- (2009) JR Wu-Wong BRITISH JOURNAL OF PHARMACOLOGY
- Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes
- (2009) Dariush Mokhtari et al. CLINICAL SCIENCE
- Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
- (2009) G. Y. Oudit et al. DIABETES
- The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
- (2009) P.-H. Groop et al. DIABETES
- Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
- (2009) F. Persson et al. DIABETES CARE
- Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity
- (2009) P. Kar et al. DIABETIC MEDICINE
- CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone
- (2009) D. John Betteridge FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Pirfenidone Is Renoprotective in Diabetic Kidney Disease
- (2009) S. P. RamachandraRao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
- (2009) H.-H. Parving et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- PPAR-Alpha Agonist Fenofibrate Induces Renal CYP Enzymes and Reduces Blood Pressure and Glomerular Hypertrophy in Zucker Diabetic Fatty Rats
- (2008) Xueying Zhao et al. AMERICAN JOURNAL OF NEPHROLOGY
- RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
- (2008) F. Peng et al. DIABETES
- Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
- (2008) J. M. Forbes et al. DIABETES
- Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
- (2008) Pooneh Alborzi et al. HYPERTENSION
- Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents
- (2008) José A. Hernández Prada et al. HYPERTENSION
- Expanding targets of vitamin D receptor activation: downregulation of several RAS components in the kidney
- (2008) Ilkka H. Pörsti KIDNEY INTERNATIONAL
- Suppression of renin–angiotensin gene expression in the kidney by paricalcitol
- (2008) Michael Freundlich et al. KIDNEY INTERNATIONAL
- Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
- (2008) G. J. Ko et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation
- (2008) Sherma Zibadi et al. NUTRITION RESEARCH
- Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways
- (2008) Raquel Rodrigues-Díez et al. PHARMACEUTICAL RESEARCH
- Renoprotective role of the vitamin D receptor in diabetic nephropathy
- (2007) Z. Zhang et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started